Steve Almany

1.1k total citations
16 papers, 440 citations indexed

About

Steve Almany is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Epidemiology. According to data from OpenAlex, Steve Almany has authored 16 papers receiving a total of 440 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cardiology and Cardiovascular Medicine, 8 papers in Internal Medicine and 3 papers in Epidemiology. Recurrent topics in Steve Almany's work include Atrial Fibrillation Management and Outcomes (12 papers), Venous Thromboembolism Diagnosis and Management (8 papers) and Cardiac Arrhythmias and Treatments (6 papers). Steve Almany is often cited by papers focused on Atrial Fibrillation Management and Outcomes (12 papers), Venous Thromboembolism Diagnosis and Management (8 papers) and Cardiac Arrhythmias and Treatments (6 papers). Steve Almany collaborates with scholars based in United States and Germany. Steve Almany's co-authors include Peter Sick, Eberhard Grube, Gerhard Schüler, Gregory Mishkel, Karl Eugen Hauptmann, Zoltan G. Turi, David R. Holmes, Eva Kline‐Rogers, James B. Froehlich and Brian Haymart and has published in prestigious journals such as Journal of the American College of Cardiology, The American Journal of Cardiology and Journal of Thrombosis and Haemostasis.

In The Last Decade

Steve Almany

16 papers receiving 422 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steve Almany United States 10 403 104 84 70 36 16 440
Tushar Tuliani United States 6 486 1.2× 28 0.3× 88 1.0× 76 1.1× 24 0.7× 16 537
Fei Yuan Canada 9 185 0.5× 46 0.4× 38 0.5× 58 0.8× 17 0.5× 28 244
Peeyush Grover United States 9 598 1.5× 30 0.3× 46 0.5× 92 1.3× 55 1.5× 11 629
Ramin Artang United States 9 319 0.8× 145 1.4× 72 0.9× 81 1.2× 45 1.3× 16 399
Ricarda Marinigh Italy 7 392 1.0× 117 1.1× 83 1.0× 19 0.3× 83 2.3× 12 437
Alessandro Cuneo Germany 8 814 2.0× 37 0.4× 60 0.7× 97 1.4× 30 0.8× 28 875
Adeel Shahzad United Kingdom 7 422 1.0× 187 1.8× 34 0.4× 165 2.4× 17 0.5× 19 471
Bernard Witzenbichler Germany 4 451 1.1× 120 1.2× 49 0.6× 184 2.6× 13 0.4× 6 480
Ahthit Yindeengam Thailand 9 193 0.5× 28 0.3× 62 0.7× 30 0.4× 32 0.9× 33 247
Nathan H. Kander United States 8 295 0.7× 35 0.3× 139 1.7× 131 1.9× 31 0.9× 12 333

Countries citing papers authored by Steve Almany

Since Specialization
Citations

This map shows the geographic impact of Steve Almany's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steve Almany with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steve Almany more than expected).

Fields of papers citing papers by Steve Almany

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steve Almany. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steve Almany. The network helps show where Steve Almany may publish in the future.

Co-authorship network of co-authors of Steve Almany

This figure shows the co-authorship network connecting the top 25 collaborators of Steve Almany. A scholar is included among the top collaborators of Steve Almany based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steve Almany. Steve Almany is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Haymart, Brian, Eva Kline‐Rogers, Scott Kaatz, et al.. (2021). Standard Versus Higher Intensity Anticoagulation for Patients With Mechanical Aortic Valve Replacement and Additional Risk Factors for Thromboembolism. The American Journal of Cardiology. 159. 100–106. 1 indexed citations
2.
Barnes, Geoffrey D., Brian Haymart, Eva Kline‐Rogers, et al.. (2018). Extended International Normalized Ratio testing intervals for warfarin‐treated patients. Journal of Thrombosis and Haemostasis. 16(7). 1307–1312. 9 indexed citations
4.
Lau, Wei C., Francis Shannon, George Hanzel, et al.. (2017). OUTCOME-BASED COST ANALYSIS OF TRANSFEMORAL TRANSCATHETER AORTIC VALVE REPLACEMENT USING FASCIA ILIACA COMPARTMENT BLOCK AND MINIMALIST CONSCIOUS SEDATION APPROACH VERSUS GENERAL ANESTHESIA. Journal of the American College of Cardiology. 69(11). 1330–1330. 1 indexed citations
5.
Haymart, Brian, Eva Kline‐Rogers, Steve Almany, et al.. (2017). SAMe-TT2R2 predicts quality of anticoagulation in patients with acute venous thromboembolism: The MAQI2 experience. Vascular Medicine. 22(3). 197–203. 12 indexed citations
6.
Haymart, Brian, Xiaokui Gu, Eva Kline‐Rogers, et al.. (2016). Prescribing trends of atrial fibrillation patients who switched from warfarin to a direct oral anticoagulant. Journal of Thrombosis and Thrombolysis. 43(2). 283–288. 21 indexed citations
7.
Minhas, Anum, Qingmei Jiang, Xiaokui Gu, et al.. (2016). Renal function in atrial fibrillation patients switched from warfarin to a direct oral anticoagulant. Journal of Thrombosis and Thrombolysis. 42(4). 566–572. 3 indexed citations
8.
Putnam, Andrew J., Xiaokui Gu, Brian Haymart, et al.. (2015). The changing characteristics of atrial fibrillation patients treated with warfarin. Journal of Thrombosis and Thrombolysis. 40(4). 488–493. 4 indexed citations
9.
Barnes, Geoffrey D., Xiaokui Gu, Brian Haymart, et al.. (2014). The Predictive Ability of the CHADS2 and CHA2DS2-VASc Scores for Bleeding Risk in Atrial Fibrillation: The MAQI2 Experience. Thrombosis Research. 134(2). 294–299. 29 indexed citations
10.
Vanhecke, Thomas E., James E. Weber, Matthew Ebinger, et al.. (2014). Implementation of Ultraportable Echocardiography in an Adolescent Sudden Cardiac Arrest Screening Program. Clinical Medicine Insights Cardiology. 8. CMC.S15779–CMC.S15779. 4 indexed citations
11.
Barnes, Geoffrey D., Scott Kaatz, Xiaokui Gu, et al.. (2013). Warfarin use in atrial fibrillation patients at low risk for stroke: analysis of the Michigan Anticoagulation Quality Improvement Initiative (MAQI2). Journal of Thrombosis and Thrombolysis. 37(2). 171–176. 12 indexed citations
12.
Barnes, Geoffrey D., Scott Kaatz, Xiaokui Gu, et al.. (2012). Use of warfarin for venous thromboembolism prophylaxis following knee and hip arthroplasty: results of the Michigan Anticoagulation Quality Improvement Initiative (MAQI2). Journal of Thrombosis and Thrombolysis. 35(1). 10–14. 21 indexed citations
13.
Sick, Peter, Gerhard Schüler, Karl Eugen Hauptmann, et al.. (2007). Initial Worldwide Experience With the WATCHMAN Left Atrial Appendage System for Stroke Prevention in Atrial Fibrillation. Journal of the American College of Cardiology. 49(13). 1490–1495. 250 indexed citations
14.
Almany, Steve, et al.. (2006). Left atrial appendage septae not visualized with transesophageal echocardiography. Catheterization and Cardiovascular Interventions. 68(4). 542–543. 2 indexed citations
15.
Yadav, Jay S., Khaled M. Ziada, Steve Almany, Thomas P. Davis, & Flavio Castañeda. (2003). Comparison of the QuickSeal Femoral Arterial Closure System with manual compression following diagnostic and interventional catheterization procedures**See the Appendix for a complete list of investigators.. The American Journal of Cardiology. 91(12). 1463–1466. 10 indexed citations
16.
Stone, Gregg W., Campbell Rogers, Steve Ramee, et al.. (2002). Distal filter protection during saphenous vein graft stenting. Journal of the American College of Cardiology. 40(10). 1882–1888. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026